Aardvark Therapeutics (AARD) Misses Q4 EPS by 81c
Tweet
Share
E-mailGet Alerts AARD Hot Sheet
Join SI Premium – FREE
Aardvark Therapeutics (NASDAQ: AARD) reported Q4 EPS of ($0.81).
For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
- Morgan Stanley Starts Jersey Mike's Subs (JMKE) at Overweight
- UBS Downgrades Banco Santander Brasil SA (SANB11:BZ) (BSBR) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
